Drug Database
Back to search

Belgium· BE-AMP-SAM135493-00

Mino-50 50 mg

A minocycline product containing minocycline hydrochloride, registered in Belgium by Teofarma. The same ATC class is registered in 10 of our 19 countries.

ATC J01AA08

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMino-50 50 mgATCJ01AA08REGISTER NO.BE-AMP-SAM135493-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about minocycline hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Minocycline is registered in 10 of 19 countries.

Countries holding a registration under ATC J01AA08 (minocycline), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search minocycline products by name

Minocycline · ATC J01AA08

10 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Minocycline Hydrochloride
Manufacturer
Teofarma
Country
Belgium (BE)
ATC code
J01AA08
ATC class
Minocycline
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

1 priced
  • be_apb
    1074087
    EUR 12.79
  • be_apb
    0093013
  • be_apb
    0729566

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

367 interactions on record for minocycline.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check minocycline against other medicinesHow interaction checks work

Minocycline · interactions on record

367 records

  • 15 severe
  • 142 moderate
  • 28 minor
  • 128 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • AcitretinD05BB02severe
  • IsotretinoinD10AD04severe

54 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Minocycline in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All minocycline products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Minostad
  • Bulgaria · Миноциклин Екофарм
  • Cyprus · Minaxen
  • Germany · Minoplus, Skid
  • Spain · Minocin Vía Oral
  • France · Kyno, Mynocine
  • United Kingdom (Northern Ireland) · Dentomycin, Minocin Mr
  • Greece · Minocin
  • Ireland · Minocin Sa, Minosil
  • Italy · Minocin
  • Luxembourg · Klinotab, Mino
  • Malta · Minaxen
  • Netherlands · Minocycline Eurogenerics, Minocycline Hydrochloride Dihydrate Aurobindo
  • Portugal · Cipancin, Minocin
  • Romania · Minoz Ep

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf988dcb-37eb-4450-ba2c-1c088fe119e5
GET /v1/drugs/cf988dcb-37eb-4450-ba2c-1c088fe119e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Mino-50 50 mg",
  "name_fr": "Mino-50 50 mg",
  "name_nl": "Mino-50 50 mg",
  "amp_code": "SAM135493-00",
  "strengths": [
    "53.9800",
    "50.0000",
    "1.8000",
    "2.5000"
  ],
  "pack_count": 3,
  "substances": [
    "Minocycline Hydrochloride",
    "Minocycline",
    "Lactose",
    "Sorbitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Minocycline",
  "authorisation_numbers": [
    "BE135493"
  ]
}
API referenceMCP serverPlans

See everything about minocycline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console